Maintenance semi-metronomic oral cyclophospahamide and oral etoposide regimen in extensive stage small cell lung cancer (SCLC) patients after responding first line treatment
dc.contributor.author | Ozdogan, M. | |
dc.contributor.author | Kargi, A. | |
dc.contributor.author | Artac, M. | |
dc.contributor.author | Bozcuk, H. | |
dc.contributor.author | Boruban, M. C. | |
dc.contributor.author | Coskun, H. S. | |
dc.contributor.author | Mutlu, H. | |
dc.date.accessioned | 2020-03-26T17:39:10Z | |
dc.date.available | 2020-03-26T17:39:10Z | |
dc.date.issued | 2009 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description | 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology -- SEP 20-24, 2009 -- Berlin, GERMANY | en_US |
dc.description.abstract | [Abstract not Available] | en_US |
dc.description.sponsorship | European Canc Org, European Soc Med Oncol | en_US |
dc.identifier.doi | 10.1016/S1359-6349(09)71844-0 | en_US |
dc.identifier.endpage | 544 | en_US |
dc.identifier.issn | 1359-6349 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 544 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1016/S1359-6349(09)71844-0 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/23661 | |
dc.identifier.volume | 7 | en_US |
dc.identifier.wos | WOS:000270645902476 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | en_US |
dc.relation.ispartof | EJC SUPPLEMENTS | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.title | Maintenance semi-metronomic oral cyclophospahamide and oral etoposide regimen in extensive stage small cell lung cancer (SCLC) patients after responding first line treatment | en_US |
dc.type | Conference Object | en_US |